114 related articles for article (PubMed ID: 35373897)
1. Linoleic-acid-substituted polyethylenimine to silence heat shock protein 90B1 (HSP90B1) to inhibit migration of breast cancer cells.
Meenakshi Sundaram DN; Kc RB; Uludağ H
J Gene Med; 2022 Jun; 24(6):e3419. PubMed ID: 35373897
[TBL] [Abstract][Full Text] [Related]
2. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
[TBL] [Abstract][Full Text] [Related]
3. Polymeric Delivery of siRNA against Integrin-β1 (CD29) to Reduce Attachment and Migration of Breast Cancer Cells.
Meenakshi Sundaram DN; Kucharski C; Parmar MB; Kc RB; Uludağ H
Macromol Biosci; 2017 Jun; 17(6):. PubMed ID: 28160423
[TBL] [Abstract][Full Text] [Related]
4. Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells.
Parmar MB; Arteaga Ballesteros BE; Fu T; K C RB; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
J Biomed Mater Res A; 2016 Dec; 104(12):3031-3044. PubMed ID: 27465922
[TBL] [Abstract][Full Text] [Related]
5. Enabling Combinatorial siRNA Delivery against Apoptosis-Related Proteins with Linoleic Acid and α-Linoleic Acid Substituted Low Molecular Weight Polyethylenimines.
Plianwong S; Thapa B; Kc RB; Kucharski C; Rojanarata T; Uludağ H
Pharm Res; 2020 Feb; 37(3):46. PubMed ID: 32016611
[TBL] [Abstract][Full Text] [Related]
6. Additive Polyplexes to Undertake siRNA Therapy against CDC20 and Survivin in Breast Cancer Cells.
Parmar MB; K C RB; Löbenberg R; Uludağ H
Biomacromolecules; 2018 Nov; 19(11):4193-4206. PubMed ID: 30222931
[TBL] [Abstract][Full Text] [Related]
7. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
Falamarzian A; Aliabadi HM; Molavi O; Seubert JM; Lai R; Uludağ H; Lavasanifar A
J Biomed Mater Res A; 2014 Sep; 102(9):3216-28. PubMed ID: 24167124
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells.
Zhang C; Yuan W; Wu Y; Wan X; Gong Y
Life Sci; 2021 Feb; 266():118886. PubMed ID: 33310044
[TBL] [Abstract][Full Text] [Related]
9. Small hydrophobe substitution on polyethylenimine for plasmid DNA delivery: Optimal substitution is critical for effective delivery.
Thapa B; Plianwong S; Remant Bahadur KC; Rutherford B; Uludağ H
Acta Biomater; 2016 Mar; 33():213-24. PubMed ID: 26802444
[TBL] [Abstract][Full Text] [Related]
10. Breathing New Life into TRAIL for Breast Cancer Therapy: Co-Delivery of pTRAIL and Complementary siRNAs Using Lipopolymers.
Thapa B; Kc R; Bahniuk M; Schmitke J; Hitt M; Lavasanifar A; Kutsch O; Seol DW; Uludag H
Hum Gene Ther; 2019 Dec; 30(12):1531-1546. PubMed ID: 31547718
[TBL] [Abstract][Full Text] [Related]
11. A systematic comparison of lipopolymers for siRNA delivery to multiple breast cancer cell lines: In vitro studies.
Aliabadi HM; Bahadur K C R; Bousoik E; Hall R; Barbarino A; Thapa B; Coyle M; Mahdipoor P; Uludağ H
Acta Biomater; 2020 Jan; 102():351-366. PubMed ID: 31760224
[TBL] [Abstract][Full Text] [Related]
12. siRNA therapy in cutaneous T-cell lymphoma cells using polymeric carriers.
Sahin B; Fife J; Parmar MB; Valencia-Serna J; Gul-Uludağ H; Jiang X; Weinfeld M; Lavasanifar A; Uludağ H
Biomaterials; 2014 Nov; 35(34):9382-94. PubMed ID: 25128374
[TBL] [Abstract][Full Text] [Related]
13. Designing Nanomedicines for Breast Cancer Therapy.
Abbasi Dezfouli S; Rajendran AP; Claerhout J; Uludag H
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892241
[TBL] [Abstract][Full Text] [Related]
14. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
[TBL] [Abstract][Full Text] [Related]
15. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line.
Montazeri Aliabadi H; Landry B; Mahdipoor P; Uludağ H
Mol Pharm; 2011 Oct; 8(5):1821-30. PubMed ID: 21838308
[TBL] [Abstract][Full Text] [Related]
17. Effect of siRNA pre-Exposure on Subsequent Response to siRNA Therapy.
Aliabadi HM; Mahdipoor P; Kucharsky C; Chan N; Uludağ H
Pharm Res; 2015 Dec; 32(12):3813-26. PubMed ID: 26129766
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.
Yang H; Zhou H; Feng P; Zhou X; Wen H; Xie X; Shen H; Zhu X
J Exp Clin Cancer Res; 2010 Jul; 29(1):92. PubMed ID: 20618976
[TBL] [Abstract][Full Text] [Related]
19. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.
Li G; Cai M; Fu D; Chen K; Sun M; Cai Z; Cheng B
Cell Physiol Biochem; 2012; 30(6):1481-90. PubMed ID: 23208072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
